Table 1.
Summary of the articles included in the review.
| 1st Author, Year (Country) |
Study Design | Participants (% Female) | Age Range (Mean ± SD) |
Study Length (Follow-Up) |
Treatment |
|---|---|---|---|---|---|
| Bao [20], 2022 (China) |
R/P | 161 (54.7) | 8–13 years (10.4 ± 1.2) |
1 year (6 months) |
HALs, SALs |
| Bao [29], 2022 (China) |
R/P | 157 (54.1) | 8–13 years (10.4 ± 1.2) |
2 years (6 months) |
HALs, SALs |
| Huang [26], 2022 (China) |
Not R/RS | 107 (46.7) | 7–12 years (9.1 ± 1.0) |
1 year (6 months) |
DIMSs, DIMSs + A |
| Lam [18], 2020 (China) |
R/P | 160 (43.8) | 8–13 years (10.1 ± 1.4) |
2 years (6 months) |
DIMSs |
| Liu J [27], 2023 (China) |
Not R/RS | 10,477 (48.3) | 6–16 years (11.0 ± 2.5) |
2 years (6 months) |
DIMSs |
| Liu X [19], 2023 (China) |
R/P | 96 (51.0) | 8–12 years (10.0 ± 0.6) |
1 year (6 months) |
CARE |
| Long [28], 2023 (China) |
Not R/RS | 180 (46.1) | 6–15 years (10.5 ± 2.1) |
1 year (12 months) |
DIMSs |
| Rappon [23], 2021 (China) |
R/P | 256 (58.2) | 6–10 years (8.2 ± 1.4) |
1 year (12 months) |
DOTa, DOTb |
| Sankaridurg [30], 2022 (USA) | R/P | 119 (45.4) | 7–13 years (no data) |
1.5 years (6 months) |
HALs * |
SD, standard deviation; R, randomized; P, prospective; RS, retrospective; HALs, highly aspherical lenslets; SALs, slightly aspherical lenslets; DIMSs, defocus-incorporated multiple segments; A, atropine; CARE, cylindrical annular refractive element; DOT, diffusion optics technology (a and b are two models of DOT lenses, differing in diffusor element density); * data assessed at the 6-month follow-up (subsequent follow-up periods are not applicable due to particularities of the study design).